Serveur d'exploration Tocilizumab - Analysis (France)

Index « Auteurs » - entrée « Patrick Garnero »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Patrick Durez < Patrick Garnero < Patrick Hundsdoerfer  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 2.
Ident.Authors (with country if any)Title
000706 (2010) Jun Hashimoto [Japon] ; Patrick Garnero [France] ; Désirée Van Der Heijde [Pays-Bas] ; Nobuyuki Miyasaka [Japon] ; Kazuhiko Yamamoto [Japon] ; Shinichi Kawai [Japon] ; Tsutomu Takeuchi [Japon] ; Hideki Yoshikawa [Japon] ; Norihiro Nishimoto [Japon]Humanized anti-interleukin-6-receptor antibody (tocilizumab) monotherapy is more effective in slowing radiographic progression in patients with rheumatoid arthritis at high baseline risk for structural damage evaluated with levels of biomarkers, radiography, and BMI: data from the SAMURAI study
000725 (2010) Patrick Garnero [France] ; Elizabeth Thompson [Royaume-Uni] ; Thasia Woodworth [Royaume-Uni] ; Josef S. Smolen [Autriche]Rapid and Sustained Improvement in Bone and Cartilage Turnover Markers With the Anti-Interleukin-6 Receptor Inhibitor Tocilizumab Plus Methotrexate in Rheumatoid Arthritis Patients With an Inadequate Response to Methotrexate: Results From a Substudy of the Multicenter Double-Blind, Placebo-Controlled Trial of Tocilizumab in Inadequate Responders to Methotrexate Alone

List of associated KwdEn.i

Nombre de
documents
Descripteur
2Antibodies, Monoclonal (therapeutic use)
2Antibodies, Monoclonal, Humanized
2Arthritis, Rheumatoid (drug therapy)
2Humans
1Amino Acids (urine)
1Antineoplastic agent
1Antirheumatic Agents (therapeutic use)
1Antirheumatic agent
1Arthritis, Rheumatoid (blood)
1Arthritis, Rheumatoid (pathology)
1Arthritis, Rheumatoid (urine)
1Biomarkers (blood)
1Biomarkers (urine)
1Body Mass Index
1Bone remodeling
1Cartilage
1Cartilage, Articular (drug effects)
1Cartilage, Articular (physiology)
1Chondrogenesis (drug effects)
1Chondrogenesis (physiology)
1Chronic
1Collagen Type I
1Collagen Type I (urine)
1Collagen Type II (blood)
1Disease Progression
1Double-Blind Method
1Drug Therapy, Combination
1Drug Tolerance
1Female
1Health Status
1Human
1Immunomodulator
1Improvement
1Interleukin 6
1Joints (pathology)
1Male
1Matrix Metalloproteinase 3 (blood)
1Methotrexate
1Methotrexate (therapeutic use)
1Middle Aged
1Osteocalcin (blood)
1Osteogenesis (drug effects)
1Osteogenesis (physiology)
1Peptide Fragments (blood)
1Peptides
1Peptides (urine)
1Procollagen (blood)
1Prospective Studies
1Rheumatoid arthritis
1Rheumatology
1Tocilizumab
1Treatment Outcome

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/France/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/Author.i -k "Patrick Garnero" 
HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/Author.i  \
                -Sk "Patrick Garnero" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/France/Analysis/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    France
   |étape=   Analysis
   |type=    indexItem
   |index=    Author.i
   |clé=    Patrick Garnero
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021